The Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) has imposed an administrative monetary penalty of $249,480.50 on Marouf Management Inc. This penalty, issued on November 4, 2024, follows a compliance examination carried out in 2023, which uncovered significant failures in Marouf’s anti-money laundering (AML) practices.
Swedbank, one of Sweden’s most prominent banks, is facing a fine of approximately €1,148,415.25 (SEK 12,500,000) after a regulatory investigation found significant gaps in its compliance with Sweden's protective security regulations. The fine comes from Finansinspektionen, Sweden's financial supervisory authority, following a detailed probe into the bank’s security practices between July 2022 and January 2024.
As excitement builds for the National Football League’s 2025 season schedule release, the Federal Trade Commission (FTC) is putting the heat on StubHub. The nation’s largest ticket exchange and resale platform is now under the FTC's watch for allegedly misrepresenting ticket prices in violation of the agency’s new transparency rule.
Goldman Sachs has agreed to pay a $1.45 million fine as part of a settlement with FINRA, the industry's self-regulatory body, following multiple reporting failures and supervision lapses between 2020 and 2023. This settlement, which includes a censure, comes after the firm struggled to meet crucial regulatory requirements, notably around the Consolidated Audit Trail (CAT) and trade reporting, exposing gaps in its internal compliance systems.
In an effort to close the book on several rule violations, Webull Financial LLC has agreed to pay a $1.6 million fine and accept a censure from FINRA. The case highlights significant lapses in supervision and transparency by a firm that has become a key player in self-directed retail trading. With this settlement, Webull seeks to put a period on a series of compliance missteps that have made waves in the financial regulatory world.
Assertio Therapeutics has agreed to pay $3.6 million to resolve allegations tied to misleading marketing practices involving its fentanyl nasal spray, Lazanda. The settlement was announced by the Department of Justice on May 5, 2025, addressing claims that Assertio’s marketing led to false billing for prescriptions that were not medically justified.
The Federal Trade Commission (FTC) has filed an amicus brief in support of the Department of Justice’s (DOJ) Revised Proposed Final Judgment (RPFJ) aimed at addressing Google's violations of antitrust laws, specifically in relation to its monopolistic practices in search services and online advertising. The FTC, as the nation’s primary privacy enforcement agency, emphasized the importance of privacy protections within the proposed settlement.